Document ID: FDA-2008-N-0038-0058
Agency: fda
Document Type: Notice
Title: Bisphenol A Subcommittee of the Science Board to the Food and Drug Administration; Notice of Meeting
Posted Date: 2008-08-15T04:00Z

[Federal Register: August 15, 2008 (Volume 73, Number 159)]
[Notices]               
[Page 47957]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15au08-72]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2008-N-0038]

 
Bisphenol A Subcommittee of the Science Board to the Food and 
Drug Administration; Notice of Meeting

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

    This notice announces the following meeting: Bisphenol A (BPA) 
Subcommittee of the Science Board to the Food and Drug Administration 
(FDA) meeting. The topic to be discussed is the draft assessment of BPA 
for use in food contact applications. The Subcommittee will hear and 
discuss the draft assessment of BPA for use in food contact 
applications, including oral presentations from the public.
    Date and Time: The meeting will be held on September 16, 2008, at 9 
a.m. to 3:30 p.m.
    Location: Hilton Washington, WashingtonDC/Rockville Executive 
Meeting Center, Plaza Ballroom, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Carlos Pe[ntilde]a, Office of Science and Health 
Coordination, Office of the Commissioner (HF-33), Food and Drug 
Administration, 5600 Fishers Lane, (for express delivery, rm. 14B-08) 
Rockville, MD 20857, 301-827-3340, or by e-mail: 
Carlos.Pe[ntilde]a@fda.hhs.gov or FDA Advisory Committee Information 
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
3014512603. Please call the Information Line for up-to-date information 
on this meeting. A notice in the Federal Register about last minute 
modifications that impact a previously announced advisory committee 
meeting cannot always be published quickly enough to provide timely 
notice. Therefore, you should always check the agency's Web site and 
call the appropriate advisory committee hot line/phone line to learn 
about possible modifications before coming to the meeting.
    Agenda: The Subcommittee will hear and discuss the draft assessment 
of BPA for use in food contact applications, including oral 
presentations from the public. FDA's draft assessment of BPA and FDA's 
charge to the Subcommittee will be posted on or after August 15, 2008, 
on FDA's Web site at http://www.fda.gov/ohrms/dockets/ac/acmenu.htm, 
click on the year 2008 and scroll down to the appropriate advisory 
committee link.
    FDA intends to make background material available to the public no 
later than 2 business days before the meeting. If FDA is unable to post 
the background material on its Web site prior to the meeting, the 
background material will be made publicly available at the location of 
the advisory committee meeting, and the background material will be 
posted on FDA's Web site after the meeting. Background material is 
available at http://www.fda.gov/ohrms/dockets/ac/acmenu.htm, click on 
the year 2008 and scroll down to the appropriate advisory committee 
link.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the Subcommittee. 
Written submissions may be made to the contact person on or before 
September 12, 2008. Oral presentations from the public will be 
scheduled between approximately 11 a.m. and 12 noon and between 
approximately 1 p.m. and 2 p.m. on September 16, 2008. Those desiring 
to make formal oral presentations should notify the contact person and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation on or before September 4, 2008. Time allotted 
for each presentation may be limited. If the number of registrants 
requesting to speak is greater than can be reasonably accommodated 
during the scheduled open public hearing session, FDA may conduct a 
lottery to determine the speakers for the scheduled open public hearing 
session. The contact person will notify interested persons regarding 
their request to speak by September 5, 2008.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Dr. Carlos 
Pe[ntilde]a at least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee 
meetings. Please visit our Web site at http://www.fda.gov/oc/advisory/
default.htm for procedures on public conduct during advisory committee 
meetings.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: August 11, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-18864 Filed 8-14-08; 8:45 am]

BILLING CODE 4160-01-S